Iconovo

Lund, Sweden

Iconovo is a developer of inhalers for drugs that treat conditions such as asthma and COPD.

$51K raised

Mar 2023

Grant

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Iconovo raised?

Iconovo has raised $51K in total funding. The most recent round was Grant. The last funding was announced in March 2023.

Who are Iconovo's investors?

Iconovo's investors include Bill & Melinda Gates Foundation, Swelife.

Where is Iconovo headquartered?

Iconovo is headquartered in Lund, Sweden.

What does Iconovo do?

Iconovo is a developer of inhalers for drugs that treat conditions such as asthma and COPD.

What stage is Iconovo at?

Iconovo is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated March 31, 2023.

MLA

"Iconovo — Funding & Investors." VCBacked, March 31, 2023, https://www.vcbacked.co/company/iconovo. Accessed July 1, 2026.

APA

VCBacked. (2023). Iconovo — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/iconovo

Wikipedia (cite web)

{{cite web |title=Iconovo — Funding & Investors |url=https://www.vcbacked.co/company/iconovo |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated March 31, 2023.